Nirvana Life Sciences Inc.
NIRVX
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.08% | 0.00% | -31.58% | 375.00% | 0.00% |
| Total Receivables | 4.48% | 10.74% | 0.00% | -11.68% | 0.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.04% | 10.53% | -5.67% | 0.00% | 0.71% |
|
|
|||||
| Total Current Assets | 2.04% | 10.53% | -5.67% | 0.00% | 0.71% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.04% | 10.53% | -5.67% | 0.00% | -89.96% |
|
|
|||||
| Total Accounts Payable | 4.90% | -15.87% | -22.37% | 125.74% | -25.68% |
| Total Accrued Expenses | 18.63% | 16.48% | -78.81% | 7.95% | 3.69% |
| Short-term Debt | 7.05% | 29.33% | 6.17% | 6.10% | 35.48% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 12.05% | 7.25% | -63.83% | 18.83% | 1.31% |
|
|
|||||
| Total Current Liabilities | 12.05% | 7.25% | -63.83% | 18.83% | 1.31% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 7.05% | 29.33% | 6.17% | 6.10% | 35.48% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 114.14% | -- | -- | -- | -85.44% |
| Total Liabilities | 18.77% | 14.75% | -63.83% | 16.52% | -9.20% |
|
|
|||||
| Common Stock & APIC | 3.30% | -1.38% | 13.71% | 4.74% | -3.72% |
| Retained Earnings | -4.58% | 0.59% | 0.14% | -6.75% | 2.85% |
| Treasury Stock & Other | 6.24% | -3.90% | -0.17% | 7.58% | -6.07% |
| Total Common Equity | -19.50% | -14.99% | 64.81% | -16.90% | -3.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -19.50% | -14.99% | 64.81% | -16.90% | -3.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | -8.33% | 0.00% | 10.00% | -2.56% |
| Total Equity | -19.33% | -14.92% | 64.60% | -16.77% | -3.54% |
|
|
|||||